Cover Image
市場調查報告書

病毒性肝炎/反轉錄病毒診斷檢驗的全球市場:2015年∼2019年

Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 342636
出版日期 內容資訊 英文 85 Pages
訂單完成後即時交付
價格
Back to Top
病毒性肝炎/反轉錄病毒診斷檢驗的全球市場:2015年∼2019年 Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019
出版日期: 2015年10月21日 內容資訊: 英文 85 Pages
簡介

病毒性肝炎/反轉錄病毒診斷檢驗,利用於篩檢、診斷、疾病管理等。由於技術的進步,不僅在醫院和診療所,患者也能在家進行診斷試驗。病毒性肝炎/反轉錄病毒診斷檢驗市場,預計從2014年到2019年期間,年複合成長率成長10.83%。

本報告提供全球病毒性肝炎/反轉錄病毒診斷檢驗市場相關調查分析、產業概要、地區市場概要、推動市場的要素、市場課題、市場趨勢、主要供應商等相關彙整。

第1章 摘要整理

第2章 報告的範圍

第3章 市場調查的方法

  • 調查方法
  • 經濟指標

第4章 簡介

第5章 概要

  • 肝炎
  • HIV

第6章 市場的狀況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各地區市場區隔

  • 病毒性肝炎/反轉錄病毒診斷檢驗市場:各地區
  • 南北美洲
  • 歐洲/中東/非洲
  • 亞太地區

第8章 主要國家

  • 巴西
  • 中國

第9章 推動市場的要素

第10章 促進要素的影響

第11章 市場課題

第12章 促進要素與課題的影響

第13章 市場趨勢

第14章 供應商狀況

  • 競爭模式
  • 市場佔有率分析:2014年
  • 其他主要供應商

第15章 主要供應商分析

  • Abbott Diagnostics
  • Alere
  • Chembio
  • DiaSorin
  • Roche Diagnostics

第16章 附錄

第17章 Technavio的其他報告

圖表

目錄
Product Code: IRTNTR7415

About viral hepatitis and retrovirus diagnostic tests

Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in supporting decision-making in clinical conditions. Advances in diagnostic testing systems and assays have led to the development of self-testing, which are easy to perform and convenient for both medical professionals and patients. The diagnostic tests for viral hepatitis and retrovirus can be carried out in hospitals, clinics, or at home.

Technavio's analysts forecast the global viral hepatitis and retrovirus diagnostic tests market to grow at a CAGR of 10.83% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global viral hepatitis and retrovirus diagnostic tests market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of assays and instruments for diagnostic testing of viral hepatitis and retrovirus.

Technavio's report, Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • APAC
  • Europe
  • Latin America
  • MEA
  • North America

Key vendors

  • Abbott Diagnostics
  • Alere
  • Chembio
  • DiaSorin
  • Roche Diagnostics

Other Prominent Vendors

  • Amkay Products
  • AOV International
  • Apothecaries Sundries Manufacturing
  • Beckman Coulter
  • Becton Dickinson
  • Bhat Bio-tech
  • bioMerieux
  • Bioneovan
  • Bio-Rad
  • Cepheid
  • Enzo Biochem
  • Fujirebio
  • Gemc Technology (Zhengzhou)
  • Grifols
  • Hangzhou Deangel Biological Engineering
  • Hangzhou Heo Bio-Tech
  • Hologic
  • Horiba
  • Innovation Biotech (Beijing)
  • Jaksh Enterprises
  • Krishco Medical Products
  • Micro Sidd
  • Nantong Egens Biotechnology
  • Nexus Lifecare
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Qingdao Hightop Biotech
  • Scienion
  • SeraCare
  • Shanghai Kehua Bio-engineering
  • Siemens Healthcare Diagnostics
  • Span Diagnostics
  • Synergy Healthcare
  • Thermo Fisher Scientific
  • Transasia Bio-Medicals
  • Wako
  • YVR Medivision
  • Zhuhai Encode Medical Engineering

Market driver

  • High prevalence and awareness of HIV and hepatitis
  • For a full, detailed list, view our report

Market challenge

  • Limitation of closed system
  • For a full, detailed list, view our report

Market trend

  • Increased usage of POC diagnostic tests
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Overview

  • Hepatitis
  • HIV

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Geographical segmentation

  • Global viral hepatitis and retrovirus diagnostic tests market by geographical segmentation
  • Viral hepatitis and retrovirus diagnostic tests market in Americas
  • Viral hepatitis and retrovirus diagnostic tests market in EMEA
  • Viral hepatitis and retrovirus diagnostic tests market in APAC

PART 08: Key focus countries

  • Brazil
  • China

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 15: Key vendor analysis

  • Abbott Diagnostics
  • Alere
  • Chembio
  • DiaSorin
  • Roche Diagnostics

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global endemicity of hepatitis A infection
  • Exhibit 03: Endemicity pattern of hepatitis B across different regions
  • Exhibit 04: Prevalence rates of hepatitis B in APAC
  • Exhibit 05: Acute hepatitis B infection by age groups (2005-2013)
  • Exhibit 06: Chronic hepatitis B infection by age groups (2005-2013)
  • Exhibit 07: Prevalence of hepatitis B in US (2005-2013)
  • Exhibit 08: Prevalence rates of hepatitis C across different geographies (2012)
  • Exhibit 09: Prevalence data of hepatitis C in APAC
  • Exhibit 10: Prevalence data of hepatitis C in Europe
  • Exhibit 11: Prevalence data of hepatitis C in Caribbean and Latin America
  • Exhibit 12: Prevalence data of hepatitis C in Middle-East and North Africa
  • Exhibit 13: Prevalence data of hepatitis C in North America
  • Exhibit 14: Prevalence data of hepatitis C in Sub-Saharan Africa
  • Exhibit 15: Medical cost for chronic viral hepatitis
  • Exhibit 16: Medical cost for treatment of hepatitis C-related infections
  • Exhibit 17: Demographic statistics for HIV (2014)
  • Exhibit 18: Low-cost portable tests for HIV diagnosis
  • Exhibit 19: Top 10 countries with highest number of healthcare facilities providing HIV testing in 2013
  • Exhibit 20: Global viral hepatitis and retrovirus diagnostic tests market
  • Exhibit 21: Global viral hepatitis and retrovirus diagnostic tests market 2014-2019 ($ millions)
  • Exhibit 22: Five forces analysis
  • Exhibit 23: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2014
  • Exhibit 24: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2019
  • Exhibit 25: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2014-2019
  • Exhibit 26: Viral hepatitis and retrovirus diagnostic tests market in Americas 2014-2019 ($ millions)
  • Exhibit 27: Viral hepatitis and retrovirus diagnostic tests market in EMEA 2014-2019 ($ millions)
  • Exhibit 28: Top countries in APAC with highest number of HIV patients (2012)
  • Exhibit 29: Viral hepatitis and retrovirus diagnostic tests market in APAC 2014-2019 ($ millions)
  • Exhibit 30: Viral hepatitis and retrovirus diagnostic tests market in Brazil 2014-2019 ($ millions)
  • Exhibit 31: Viral hepatitis and retrovirus diagnostic tests market in China 2014-2019 ($ millions)
  • Exhibit 32: Impact of drivers
  • Exhibit 33: Impact of drivers and challenges
  • Exhibit 34: Abbott Diagnostics: Key takeaways
  • Exhibit 35: Alere: Key takeaways
  • Exhibit 36: Chembio: Key takeaways
  • Exhibit 37: DiaSorin: Key takeaways
  • Exhibit 38: Roche Diagnostics: Key takeaways
  • Exhibit 39: Abbott Diagnostics: Key business offerings
  • Exhibit 40: Alere: Business segmentation by revenue 2014
  • Exhibit 41: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 42: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
  • Exhibit 43: Chembio: Business segmentation by revenue 2014
  • Exhibit 44: Chembio: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 45: Chembio: Geographical segmentation by revenue 2014
  • Exhibit 46: DiaSorin: Business segmentation by revenue 2013 and 2014
  • Exhibit 47: DiaSorin: Geographical segmentation by revenue 2014
Back to Top